University Of Medicine And Dentistry Of New Jersey

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1970-01-01

Employees: -

Market Cap: -

Website: http://www.umdnj.edu/

Clinical Trials

Trial to Enhance Adherence to Multiple Guidelines

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Diabetes Mellitus
Hypertension
Lung Diseases
Asthma
Atherosclerosis
Heart Diseases

Interventions: Other: practice guideline adherence

First Posted Date: 2005-09-20

Last Posted Date: 2017-07-11

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 60

Registration Number: NCT00201227

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Phase 4

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Social Anxiety Disorder

First Posted Date: 2005-09-15

Last Posted Date: 2007-01-29

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 18

Registration Number: NCT00177008

Locations: 🇺🇸
Robert Wood Johnson Medical School - Psychiatry Dept., Piscataway, New Jersey, United States

The Use of HEMOBAG to Salvage Blood After Cardiac Surgery

Phase 2

Terminated

Conditions: Cardiopulmonary Bypass
Cardiac Diseases

First Posted Date: 2005-09-15

Last Posted Date: 2007-05-01

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 50

Registration Number: NCT00176657

Locations: 🇺🇸
UMDNJ, Newark, New Jersey, United States

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Completed

Conditions: Osteoporosis
Prostate Cancer

First Posted Date: 2005-09-15

Last Posted Date: 2011-08-12

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 27

Registration Number: NCT00176579

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Not Applicable

Terminated

Conditions: Fatigue
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2005-09-15

Last Posted Date: 2011-05-17

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 30

Registration Number: NCT00176540

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

Phase 4

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Betaseron
Drug: Copaxone

First Posted Date: 2005-09-15

Last Posted Date: 2021-11-16

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 75

Registration Number: NCT00176592

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States

A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity

Not Applicable

Terminated

Conditions: Neurotoxicity Syndromes

First Posted Date: 2005-09-15

Last Posted Date: 2009-12-11

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 20

Registration Number: NCT00176553

Locations: 🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Phase 1

Terminated

Conditions: Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

Interventions: Biological: rituximab
Biological: therapeutic allogeneic lymphocytes

First Posted Date: 2005-09-15

Last Posted Date: 2013-09-17

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 2

Registration Number: NCT00176475

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

A GameBoy as a Distraction Before Surgery in Children

Phase 2

Completed

Conditions: Anxiety

First Posted Date: 2005-09-15

Last Posted Date: 2016-10-06

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 158

Registration Number: NCT00176670

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: epirubicin
Drug: vinorelbine

First Posted Date: 2005-09-15

Last Posted Date: 2017-03-23

Lead Sponsor: University of Medicine and Dentistry of New Jersey

Target Recruit Count: 31

Registration Number: NCT00176488

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy